摘要
目的探讨美沙拉嗪联合培菲康治疗溃疡性结肠炎的临床疗效。方法将72例溃疡性结肠炎患者随机分为观察组与对照组,每组各36例,对照组单纯采用美沙拉嗪进行治疗,观察组在此基础上加用培菲康,两组治疗周期均为7周,治疗结束后评定疗效。结果治疗结束后,观察组临床总有效率为91.67%,对照组临床总有效率为63.89%,两组临床疗效差异显著,具有统计学意义(P<0.05)。结论美沙拉嗪联合培菲康治疗溃疡性结肠炎的临床疗效显著,值得在临床推广应用。
Objective To observe the clinical effect of mesalazine combination with bifico for patients with ulcerative colitis. Methods 72 patients with ulcerative colitis were randomly divided into observation group and control group, 36 patients in each group. The patients in the control group were given mesalazine therapy, while the patients in the observation group were additionally given bifico with 7 weeks months as a course. The clinical effect of the two groups were observed after the treatment. Results The total effective rate of the observation group was 91.67% compared with the control group （63.89%）, the difference was statistically significant（P0.05）. Conclusion The combination of mesalazine and bifico is effective in treatment of ulcerative colitis, and is worthy of clinical application.
出处
《中外医疗》
2013年第12期18-19,共2页
China & Foreign Medical Treatment
